x |
| Idenix Pharmaceuticals Experiencing Revenue Downtrend While its Industry is in an Uptrend |
|
Stock Quote: (NGM:IDIX) |
| 11/05/2009 |
|
| 3.00 |
+0.05 |
+1.69% |
80,642 |
|
| Idenix Pharmaceuticals Experiencing Revenue Downtrend While its Industry is in an Uptrend |
|
| Last |
Price Change |
% Chg |
Volume |
|
|
New York, NY, November 5, 2009,T12-NEWS reports that Revenue for Idenix Pharmaceuticals (NASDAQ:IDIX) for its trailing twelve months (TTM) ended September 30, 2009 was $13,835,000, a -24.74% decrease ... read full story |
|
|
|
|